cargo-tx.comHealthcare / BioTech & PharmaFounded: 2021Funding to Date: $131.46MM
Cargo Therapeutics is a biotechnology company that specializes in developing precision therapeutics for cancer treatment. Their proprietary technology platform enables the targeted delivery of small molecules and biologics to cancer cells, while minimizing off-target effects on healthy cells. The company's lead product candidate, CT-100, is a novel therapeutic that selectively targets cancer cells expressing the protein EphA2, which is overexpressed in a variety of solid tumors. Cargo Therapeutics aims to improve patient outcomes and reduce the toxicity of cancer treatments with their precision therapeutics.
View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Cargo Therapeutics.
Become part of the Secondary Marketplace, catering to both individual and institutional investors.